Robert Chung

Partner, New York



Robert advises clients on matters relating to mergers and acquisitions. He has represented numerous national and international clients, guiding them through the different phases of significant transactions.

Robert has represented acquirers, targets, boards of directors, special committees and investment banks across a variety of transactions. In addition to his broad M&A experience, Robert also regularly represents investment banking firms in their role as financial advisors in M&A transactions.

Robert has experience on several high-profile billion dollar transactions, including Zimmer Holdings, Inc.'s US$13.35 billion acquisition of LVB Acquisition, Inc. and Omnicare, Inc. in its US$12.7 billion sale to CVS Health Corporation. He also represented a consortium composed of Brookfield Infrastructure, its institutional partners and GIC, Singapore's sovereign wealth fund, on the US$8.4 billion acquisition of Genesee & Wyoming Inc. (NYSE:GWR), His experience extends across several industry sectors including the entertainment, retail, insurance, energy, technology, healthcare and pharmaceutical industries.

Robert is a partner in the Mergers & Acquisitions Group, a global practice focusing on effective deal execution and optimized efficiency for clients across a variety of large and complex transactions.

Bars and Courts
New York
District of Columbia
US District Court for the Central District of California
Northwestern University School of Law
Brown University


Macquarie Infrastructure Corp. (NYSE: MIC) and its related entities in the sale of three businesses, including the US$4.475 billion sale of its Atlantic Aviation business to KKR and the US$514 million sale of the MIC Hawaii businesses to Argo Infrastructure Partners, LP.

Brookfield Infrastructure Partners in its bid to acquire Inter Pipeline Ltd., a Canadian company publicly traded on the Toronto Stock Exchange, for an implied value of CAD$13.5 billion.

ION Acquisition Corp 1 Ltd. (NYSE: IACA), a SPAC, in its US$2.6 billion business combination with Ltd., an Israeli private company and a global leader in powering recommendations for the open web.

Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) and the Special Committee of its Board of Directors in the US$1.56 billion acquisition of GNOG by DraftKings Inc., a leading digital sports entertainment and gaming company.

ION Acquisition Corp 2 Ltd. (NYSE: IACB), a SPAC, in its US$1.3 billion business combination with Innovid, Inc., a global leader in connected TV ad delivery and measurement.

The Special Committee of Cellular Biomedicine Group, Inc. in its sale to a consortium including certain members of CBMG management, CBMG stockholders and financial sponsors.

Alberta Investment Management Corporation (Aimco), in a joint venture with The AES Corporation (NYSE: AES) to merge the sPower development platform, a leading independent solar developer in the United States, with AES' US-based clean energy development business to accelerate the safe, reliable transition to cleaner energy solutions in the United States.

A consortium composed of Brookfield Infrastructure, its institutional partners and GIC, Singapore's sovereign wealth fund, on the US$8.4 billion acquisition of Genesee & Wyoming Inc. (NYSE:GWR), a freight railroad owner and operator based in the United States. The transaction was named "Private Equity Deal of the Year" by IFLR 2020.

LifePoint Health, Inc. (NASDAQ: LPNT) in its US$5.6 billion merger with RCCH HealthCare Partners, which is owned by certain funds managed by affiliates of Apollo Global Management, LLC (NYSE: APO).

Newmont Mining Corporation (NYSE: NEM) in its US$10 billion acquisition of Goldcorp Inc. (NYSE: GG, TSX: G).

SodaStream International Ltd. (NASDAQ/TLV: SODA) in its US$3.2 billion sale to PepsiCo, Inc. (NASDAQ: PEP).

Luxoft Holding, Inc. (NYSE: LXFT) in its US$2 billion sale to DXC Technology (NYSE: DXC).

Roark Capital Group and its portfolio company Arby's Restaurant Group, in Arby's US$2.9 billion acquisition of Buffalo Wild Wings, Inc. (NASDAQ: BWLD).

Inspire Brands, Inc., a portfolio company of Roark Capital Group, in its US$2.3 billion acquisition of Sonic Corp. (NASDAQ: SONC).

Roark Capital Group and Inspire Brands, Inc. in the acquisition of Jimmy John's LLC, a fast food sandwich restaurant chain.  

Calpine Corporation (NYSE: CPN) in its US$17 billion sale to Energy Capital Partners, an energy-focused private equity firm, and a consortium of investors including Access Industries and Canadian Pension Plan Investment Board.

PPF Group N.V., a privately held international financial and investment group in its pending acquisition of Central European Media Enterprises Ltd. (NASDAQ/Prague Stock Exchange: CETV).

Zimmer Holding's, Inc. in its acquisition of LVB Acquisition, Inc.

Zimmer Biomet (NYSE and SIX: ZBH) in its US$1.1 billion acquisition of LDR Holding Corporation (NASDAQ: LDRH).

Omnicare, Inc. in its US$12.7 billion sale to CVS Health Corporation.

Illumina, Inc. in its defense against Roche Holding Ltd.'s unsolicited cash tender offer and proxy contest.

Omnicare, Inc. in its unsolicited cash tender offer for PharMerica Corporation.

Sony/ATV and EMI Music Publishing in the sale of selected music catalogs, including catalogs owned by Virgin Music Publishing Companies and Famous UK Music Publishing, to BMG, the world's fourth-largest music publishing company.

MetLife, Inc. in its acquisition of American Life Insurance Company and certain subsequent divestitures of businesses of American Life Insurance Company.

Alimentation Couche-Tard Inc. in its unsolicited cash tender offer for Casey's General Stores, Inc.

Nordic Capital, DLJ Merchant Banking, Avista Capital and other private equity sponsors in their sale of Fougera Pharmaceuticals to Sandoz.

First Advantage Corporation in the acquisition by The First American Corporation of the outstanding minority interests of First Advantage Corporation.

Fisher Communications, Inc. in its sale to Sinclair Broadcast Group, Inc.

The Talbots, Inc. in its sale to Sycamore Partners, and in its sale of the J. Jill business to Golden Gate Capital.

King Pharmaceuticals, Inc. in its US$1.6 billion unsolicited acquisition of Alpharma Inc.

Awards and Recognition

Leading Individual for M&A in the United States, Euromoney, 2021